Prediction: Procter & Gamble Will Trade At This Price in 2027

1 hour ago 3

Vandita Jadeja

Mon, May 18, 2026 astatine 5:21 AM CDT 4 min read

Quick Read

Procter & Gamble (PG) reported Q3 FY2026 Core EPS of $1.59, beating the $1.55 consensus, with gross of $21.23B up 7.4% YoY and 5 consecutive net beats, portion the banal trades 14% beneath its 52-week precocious contempt delivering broad-based maturation crossed each segments and regions.
PG trades astatine a discount contempt cardinal spot owed to tariff headwinds ($400M after-tax) and borderline compression, but the company’s Portfolio/Supply Chain Productivity Plan targets $1.5B successful cost-of-goods-sold savings and 7,000 relation reductions by extremity of FY2027, positioning it arsenic a antiaircraft currency instrumentality with a 70-year dividend streak yielding 3%.
The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and P&G wasn't 1 of them. Get them present FREE.

Our 24/7 Wall St. terms people for Procter & Gamble (NYSE:PG) is $163.50, implying a 14.95% upside from today's price. Procter & Gamble trades astatine $142.24 arsenic of May 13, 2026, with a $330.7 cardinal marketplace headdress and a beta of 0.4.

Our proposal is buy, with 90% confidence. PG is simply a antiaircraft currency instrumentality trading good beneath caller highs, supported by expert statement and unchangeable net power.

The expert who called NVIDIA successful 2010 conscionable named his apical 10 stocks and P&G wasn't 1 of them. Get them present FREE.

Metric

Value

Current Price	$142.24
24/7 Wall St. Price Target	$163.50
Upside	14.95%
Recommendation	BUY
Confidence Level	90%

A Defensive Name That Sold Off Into Earnings Strength

PG is down 7.84% implicit 12 months, disconnected 3.83% successful the past week, and hardly affirmative twelvemonth to day astatine +0.69%. Shares beryllium astir 14% beneath the 52-week precocious of $166.21 and good supra the 52-week debased of $135.63.

Fundamentals don't warrant the weakness. Q3 FY2026, filed April 24, 2026, delivered Core EPS of $1.59 against a $1.55 consensus, with gross of $21.23 billion, up 7.4% YoY. Beauty grew 7% organic, and each conception posted growth. CEO Shailesh Jejurikar said the 4th showed "a coagulated acceleration successful top-line results... broad-based maturation crossed merchandise categories and regions." That marks 5 consecutive net beats.

The Case for $175+

The bull lawsuit is credible. Our model's bull script points to $174.78 by May 2027, a 22.87% full return. Drivers see the Portfolio, Supply Chain and Productivity Plan targeting up to 7,000 non-manufacturing relation reductions by extremity of FY2027, positive a Supply Chain 3.0 programme aimed astatine $1.5 cardinal successful cost-of-goods-sold savings. Innovation successful synthetic biology, premium Skin Care mix, and emerging-market penetration successful India, MEA, and Greater China underpin the multi-year story.

Read Entire Article